The new crop of portable jump starters means you'll never be stuck waiting on a tow. Here are the devices we'd trust.
Plug Power’s fourth-quarter results were encouraging. The hydrogen production and fuel cell company beat estimates with 17.6% year-over-year revenue growth and a smaller loss than expected. It’s ...
Luuk Herssen is the new character who will become playable during phase 2 of patch 3.1. Galbrena in Wuthering Waves will also get her first-ever rerun banner for the update. Here is the second phase ...
The General Services Administration has unveiled the first phase of awards under the Alliant 3 governmentwide acquisition contract, a multiple-award vehicle supporting federal IT modernization. The ...
Hosted on MSN
Mazda CX-60 plug-in hybrid full review
In this review, we test the Mazda CX 60 Plug In Hybrid to see if it offers the right balance of performance, comfort, and efficiency for families. With over 300 horsepower and all wheel drive, it ...
Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...
The biggest stories of the day delivered to your inbox.
Super Bowl LX is finally here! Well, it's almost two weeks away — but the matchup is set and a plethora of betting opportunities are already live across the market. Before we dive into some early ...
Three classic Far Cry games are getting updates later this week to run at 60 frames per second on modern platforms. The official Far Cry account posted a cryptic message on X, showing three sentences ...
Secretary Marco Rubio insisted the U.S. has a plan for post-transition governing in Venezuela, pushing back on criticism from Democrats who say the Trump administration moved faster to capture leader ...
Secretary of Defense Pete Hegseth and Secretary of State Marco Rubio speak to reporters after they briefed Senators on the recent US military actions in Venezuela, on Capitol Hill in Washington on Jan ...
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA. The British drugmaker had been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results